FOREST LABORATORIES$33.87
+0.28
| Last Trade: |
33.87 |
| Trade Time: |
May 16 4:16 PM Eastern Daylight Time |
| Change: |
0.28 (0.83 %) |
| Prev Close: |
33.59 |
| Open: |
33.62 |
| Bid: |
33.89 |
| Ask: |
34.00 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
4/18/2012
|
SALANS LESTER B
|
Director
|
-2,390
|
$34.30
|
-10.00%
|
|
4/17/2012
|
Weinstein Herschel S
|
SVP General Counsel
|
-4,400
|
$35.07
|
-4.23%
|
|
4/17/2012
|
Weinstein Herschel S
|
SVP General Counsel
|
-1,600
|
$35.07
|
-1.52%
|
|
3/7/2012
|
OLANOFF LAWRENCE S
|
Director
|
-179
|
$32.40
|
-0.20%
|
|
3/7/2012
|
OLANOFF LAWRENCE S
|
Director
|
-382
|
$32.39
|
-0.42%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (FRX), click here.
-
AstraZeneca has an opportunity to do something big when it brings in a new CEO.
Read More »
-
Earnings Scorecard: Forest Labs - Analyst Blog
Read More »
-
Pfizer remains very profitable and has ample cushion to adjust its cost structure to maintain a respectable level of profit gains going forward.
Read More »
-
Salix is a great candidate for growth investors.
Read More »
-
2011 was a surprisingly healthy year for drug stocks.
Read More »
-
Pfizer has to convince the Street that it can still grow, but the stock is cheap for now.
Read More »
Free Reports
|
|
